Synbio Tech Inc. (TPEX:1295)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
57.20
-0.10 (-0.17%)
Apr 29, 2026, 1:30 PM CST
-19.32%
Market Cap 1.97B
Revenue (ttm) 1.04B
Net Income (ttm) 175.97M
Shares Out 34.48M
EPS (ttm) 5.28
PE Ratio 10.81
Forward PE n/a
Dividend 3.00 (5.24%)
Ex-Dividend Date Mar 27, 2026
Volume 40,525
Average Volume 70,167
Open 57.30
Previous Close 57.30
Day's Range 56.80 - 57.50
52-Week Range 56.90 - 157.50
Beta 1.23
RSI 32.24
Earnings Date May 13, 2026

About Synbio Tech

Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional strain includes SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improve digestive and ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 92
Stock Exchange Taipei Exchange
Ticker Symbol 1295
Full Company Profile

Financial Performance

In 2025, Synbio Tech's revenue was 1.04 billion, an increase of 4.97% compared to the previous year's 989.48 million. Earnings were 175.97 million, an increase of 3.43%.

Financial Statements

News

There is no news available yet.